Pediatric Care

A recent U.S. Department of Health and Human Services evidence review on treatments for pediatric gender dysphoria has prompted debate over the benefits and risks of puberty blockers, cross-sex hormones, and surgeries for minors. In a commentary for The Daily Wire, lawyer Jesse Franklin-Murdock, who represents detransitioners, outlined ten takeaways he says show substantial uncertainties and potential harms, particularly regarding bone health, neurocognitive development, cardiovascular effects and long-term outcomes.